CD4

CD4 詳細

英語名T-cell surface antigen CD4市販薬剤の数1
治験薬の数25ターゲットの別称CD4mut,CD4 Antigens,T-cell surface antigen T4/Leu-3,T-cell surface glycoprotein CD4,CD4,CD4 Molecule,CD4 Antigen (P55),CD4 Receptor,CD4 Antigen
研究&開発段階Approved
英語名T-cell surface antigen CD4
ターゲットの別称CD4mut,CD4 Antigens,T-cell surface antigen T4/Leu-3,T-cell surface glycoprotein CD4,CD4,CD4 Molecule,CD4 Antigen (P55),CD4 Receptor,CD4 Antigen
市販薬剤の数1
治験薬の数25
研究&開発段階Approved

CD4 製品リスト

  • 属性

    Protein (15)Antibody (2)Cell Grade Beads (1)

  • 製品ライブラリ

    オンライン (18)

  • Human (13)Rhesus macaque (3)Rabbit (1)Mouse (1)

  • タグ

    Fc Tag (3)His Tag (9)Fc Tag & Avi Tag (1)His Tag & Avi Tag (2)- (3)

  • マーカー

    Unconjugated (5)Biotin-labeled (3)FITC Labeled (2)PE Labeled (2)APC Labeled (1)PE-CY7 Labeled (1)AF488 Labeled (2)AF647 Labeled (1)- (1)

CD4バックグランド

T-cell surface glycoprotein CD4 is also known as T-cell surface antigen T4/Leu-3. CD4 contains three Ig-like C2-type (immunoglobulin-like) domains and one Ig-like V-type (immunoglobulin-like) domain. CD4 is accessory protein for MHC class-II antigen/T-cell receptor interaction. CD4 induces the aggregation of lipid rafts. CD4 is a primary receptor used by HIV-1 to gain entry into host T cells. HIV infection leads to a progressive reduction of the number of T cells possessing CD4 receptors. Therefore, medical professionals refer to the CD4 count to decide when to begin treatment for HIV-infected patients.

CD4分子の別称

CD4,CD4mut,LEU3

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
SemzuvolimabdB4; UB-421; mAb-B4Phase 3 ClinicalUnited Biomedical IncHIV Infections
詳細
ITV 1(Nonindustrial source)ITV-1Phase 3 ClinicalImmunotech Laboratories, Synexa Life SciencesHIV Infections
詳細
RB-0003RB-0003; BNT-111Phase 2 ClinicalBiontech Se, TronMelanoma
詳細
VRC-01-LSVRC-HIVMAB-080-00-AB; VRC-01-LSPhase 2 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)HIV Infections
詳細
VRC-07-523VRC-07-523-L S; VRC-HIVMAB075-00-AB; VRC-HIVMAB-075 -00-AB; VRC-07-523; TMB-380Phase 2 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid), Taimed Biologics IncAcquired Immunodeficiency Syndrome; HIV Infections; Sexually Transmitted Diseases, Viral
詳細
GEN-009GEN-009Phase 2 ClinicalGenocea Biosciences IncCarcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Skin Melanoma; Squamous Cell Carcinoma of Head and Neck
詳細
TregalizumabhB-F5; BT-061Phase 2 ClinicalBiotest Pharma GmbhArthritis, Rheumatoid; Asthma; Drug Hypersensitivity; Psoriasis
詳細
LotivibartVH-3810109; GSK-3810109-A; VH-109; N6LS; Z258‐N6LS; VRC-HIVMAB091-00-AB; GSK-3810109Phase 2 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)HIV Infections
詳細
MR-001MR001; MR-001Phase 2 ClinicalShenzhen Maijiarui Biotechnology Co LtdCarcinoma, Pancreatic Ductal; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
詳細
IMCY-0141IMCY-0141Phase 2 ClinicalImcyse SaMultiple Sclerosis, Relapsing-Remitting
詳細
Autologous Regulatory Т-cell TherapyPhase 2 ClinicalInstitute Of Biophysics And Cell Engineering Of National Academy Of Sciences Of BelarusScleroderma, Systemic
詳細
TMB-365TMB-365Phase 2 ClinicalTaimed Biologics IncHIV Infections
詳細
CD4-directed chimeric antigen receptor engineered T-cells (Icell Gene)CD4CAR (Icell Gene)Phase 1 ClinicalIcell Gene Therapeutics (Int'L) Ltd, Stony Brook University School Of Medicine, University Of LouisvilleLeukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia, T-Cell; Lymphoma, T-Cell
詳細
T-allo-10T-allo-10Phase 1 ClinicalStanford UniversityGraft vs Host Disease; Hematologic Diseases; Hodgkin Disease; Leukemia; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
詳細
Anti-CD4 CAR T-cell therapy (University of Pennsylvania)CAR-C34ZFNPhase 1 ClinicalUniversity Of PennsylvaniaHIV Infections
詳細
10E8.4/iMab (Aaron Diamond AIDS Research Center)TMB-370Phase 1 ClinicalAaron Diamond Aids Research Center For The City Of New York, IncHIV Infections
詳細
CD4CARICG-122; CD4CARPhase 1 ClinicaliCell Gene Therapeutics LLCLeukemia, Myelomonocytic, Chronic; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Multiple Myeloma; Mycosis Fungoides; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
MazF gene therapy (Takara Bio)Phase 1 ClinicalTakara Bio IncHIV Infections
詳細
CALRLong36 peptide (Herlev Hospital)Phase 1 ClinicalHerlev HospitalMyeloproliferative Disorders
詳細
VRC-HIVMAB060-00-ABVRC-HIVMAB060-00-AB; VRC01Phase 1 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)HIV Infections
詳細
VRC-HIVMAB0115-00-ABPhase 1 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)HIV Infections
詳細
LM-49Phase 1 ClinicalShanxi Medical University, Shanxi University Of Traditional Chinese MedicineDiabetic Nephropathies
詳細
SCRI-E2CAR_EGFRtv1SCRI-E2CAR_EGFRtv1Phase 1 ClinicalUmoja BioPharma IncOsteosarcoma
詳細
LB-1901LB1901; LB-1901Phase 1 ClinicalLeukemia, T-Cell; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral
詳細
IT-1208 (Kyowa Hakko Kirin)IT-1208Phase 1 ClinicalKyowa Hakko Kirin Co LtdNeoplasms
詳細

市販薬剤に関する情報

英語名研究コード研究開発ステージ会社オリジナル製品名最初に承認をした国最初の適応症最初に承認を受けた会社承認された日付適応症臨床試験
IbalizumabHu5A8; TMB-355; TNX-355; 5ABApprovedBiogen Inc特罗格佐, TrogarzoUnited StatesHIV InfectionsTheratechnologies Inc2018-03-06HIV Infections
詳細
  • 詳細
  • 製品リスト
  • 市販薬剤に関する情報
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8